ANASCORP 7 mg/mL
centruroides (scorpion) immune F(ab)2 (equine) · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Rare Disease Therapeutics, Inc
ANASCORP is a injection, powder, lyophilized, for solution containing centruroides (scorpion) immune f(ab)2 (equine) at 7 mg/mL, taken intravenous. Manufactured by Rare Disease Therapeutics, Inc.
Key Facts
- Brand Name
- ANASCORP
- Generic Name
- centruroides (scorpion) immune F(ab)2 (equine)
- NDC Code (Product)
66621-0150- Manufacturer
- Rare Disease Therapeutics, Inc
- Strength
- 7 mg/mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125335
- Marketing Start
- 08/03/2011
Recall History
No Recall HistoryFrequently Asked Questions
What is ANASCORP used for?
ANASCORP contains centruroides (scorpion) immune F(ab)2 (equine). It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is ANASCORP a controlled substance?
ANASCORP is not classified as a controlled substance by the DEA.
What is the generic name for ANASCORP?
The generic name for ANASCORP is centruroides (scorpion) immune F(ab)2 (equine). There are no other listed brand versions of centruroides (scorpion) immune F(ab)2 (equine).
What is the NDC code for ANASCORP 7 mg/mL?
The NDC (National Drug Code) for ANASCORP 7 mg/mL is 66621-0150, listed by Rare Disease Therapeutics, Inc.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)